GLP-1受体激动剂
-
What is the Current Landscape of Obesity Drug Development in China?
These presentations indicate that the era of domestically developed GLP-1 drugs for weight loss in China is on the horizon, with significant implications for the future of obesity treatment
-
“上帝的礼物——SGLT2抑制剂”,还能给人类带来多少惊喜?
⬆️ 欢迎参加2020中国新药CMC高峰论坛! 本文转自药渡,作者强森,点击阅读原文 强森 专栏作者 从事新药研发!学习一切与新药相关的知识!药学领域的一名小学生! …